Literature DB >> 10936209

Prevention of beta-amyloid neurotoxicity by blockade of the ubiquitin-proteasome proteolytic pathway.

A Favit1, M Grimaldi, D L Alkon.   

Abstract

In many neurodegenerative disorders, such as Alzheimer's disease, inclusions containing ubiquitinated proteins have been found in the brain, suggesting a pathophysiological role for ubiquitin-mediated proteasomal degradation of neuronal proteins. Here we show for the first time that the beta-amyloid fragment 1-40, which in micromolar levels causes the death of cortical neurons, also induces the ubiquitination of several neuronal proteins. Prevention of ubiquitination and inhibition of proteasome activity block the neurotoxic effect of beta-amyloid. These data suggest that beta-amyloid neurotoxicity may cause toxicity through the activation of protein degradation via the ubiquitin-proteasome pathway. These findings suggest possible new pharmacological targets for the prophylaxis and/or treatment of Alzheimer's disease and possibly for other related neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936209     DOI: 10.1046/j.1471-4159.2000.0751258.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Proteomic analysis of the amyloid precursor protein fragment C99: expression in yeast.

Authors:  Louis J Sparvero; Sarah Patz; Jeffrey L Brodsky; Christina M Coughlan
Journal:  Anal Biochem       Date:  2007-08-10       Impact factor: 3.365

Review 2.  Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions.

Authors:  Linnea R Freeman; Jeffrey N Keller
Journal:  Biochim Biophys Acta       Date:  2011-12-20

Review 3.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide.

Authors:  David Schubert; Thomas Soucek; Barbara Blouw
Journal:  Eur J Neurosci       Date:  2009-03-23       Impact factor: 3.386

5.  Proteasome inhibitors prevent oxidative stress-induced nerve cell death by a novel mechanism.

Authors:  Pamela Maher
Journal:  Biochem Pharmacol       Date:  2008-02-16       Impact factor: 5.858

6.  Lactacystin requires reactive oxygen species and Bax redistribution to induce mitochondria-mediated cell death.

Authors:  Sergio Perez-Alvarez; Maria E Solesio; Jorge Manzanares; Joaquín Jordán; María F Galindo
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

Review 7.  Neuroprotection against neurodegenerative diseases: development of a novel hybrid neuroprotective peptide Colivelin.

Authors:  Tomohiro Chiba; Ikuo Nishimoto; Sadakazu Aiso; Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

8.  Expression profile of a Caenorhabditis elegans model of adult neuronal ceroid lipofuscinosis reveals down regulation of ubiquitin E3 ligase components.

Authors:  Hannah V McCue; Xi Chen; Jeff W Barclay; Alan Morgan; Robert D Burgoyne
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

9.  Tetrahydroxy stilbene glucoside ameliorates H2O2-induced human brain microvascular endothelial cell dysfunction in vitro by inhibiting oxidative stress and inflammatory responses.

Authors:  Zhao Jiang; Wenhong Wang; Chengcheng Guo
Journal:  Mol Med Rep       Date:  2017-08-10       Impact factor: 2.952

Review 10.  Neuronal death in Alzheimer's disease and therapeutic opportunities.

Authors:  Rossen Donev; Martin Kolev; Bruno Millet; Johannes Thome
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.